Nurix Therapeutics (NRIX) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Nurix Therapeutics (NRIX) over the last 6 years, with Q4 2025 value amounting to 0.14.
- Nurix Therapeutics' Asset Utilization Ratio rose 5043.53% to 0.14 in Q4 2025 from the same period last year, while for Nov 2025 it was 0.14, marking a year-over-year increase of 5043.53%. This contributed to the annual value of 0.12 for FY2025, which is 1623.99% up from last year.
- As of Q4 2025, Nurix Therapeutics' Asset Utilization Ratio stood at 0.14, which was up 5043.53% from 0.15 recorded in Q3 2025.
- In the past 5 years, Nurix Therapeutics' Asset Utilization Ratio registered a high of 0.24 during Q1 2024, and its lowest value of 0.05 during Q2 2021.
- Over the past 5 years, Nurix Therapeutics' median Asset Utilization Ratio value was 0.1 (recorded in 2022), while the average stood at 0.12.
- As far as peak fluctuations go, Nurix Therapeutics' Asset Utilization Ratio surged by 16305.46% in 2023, and later plummeted by 6370.98% in 2025.
- Over the past 5 years, Nurix Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.06 in 2021, then surged by 43.73% to 0.09 in 2022, then soared by 163.05% to 0.23 in 2023, then crashed by 60.24% to 0.09 in 2024, then soared by 50.44% to 0.14 in 2025.
- Its Asset Utilization Ratio stands at 0.14 for Q4 2025, versus 0.15 for Q3 2025 and 0.15 for Q2 2025.